Draconis Pharma was founded in October 2011 after the acquisition of the Drug Discovery unit from the biopharmaceutical company Palau Pharma S.A. This operation allowed Draconis Pharma to take on a team of experienced scientific staff and to acquire cutting-edge technology in the area of drug discovery.

Draconis Pharma is supported by the technological center LEITAT, a member of TECNIO, recognized by the Ministry of Science and Innovation which aims to collaborate with companies and institutions by adding technological value to both products and processes, and focuses its activity on research, development and industrial innovation (R+D+2i).

In recent years LEITAT has made a firm commitment to expanding the biotech sector and incorporating new units within its structure.

The Draconis Pharma business model aims to become an innovative leader in the European pharmaceutical and biotechnology industry is validated by the background and expertise of LEITAT.